Results 201 to 210 of about 133,148 (292)

Low to moderate-dose off-label use of second-generation antipsychotics seems to be safe in the light of cardiac adverse effects in child psychiatric patients. [PDF]

Eur J Pediatr
Kakko K, Salmelin R, Puura K, Poutanen T.   +3 more
europepmc   +1 more source

Prolongation of renal homograft survival by inhibition of the afferent arc of the immune response

, 1966
P. J. Cleveland, H. Myron Kauffman, W. H. Graham, David M. Hume   +3 more
openalex   +1 more source

« Prolongations »

, 2016
openaire   +1 more source

Serum uric acid levels in older adults: Associations with clinical outcomes and implications for reference intervals in those aged 70 years and over

Arthritis Care &Research, Accepted Article.
Objectives Reports have linked both high and low serum uric acid (SUA) levels to adverse health outcomes. This study aimed to establish a reference interval for SUA in older adults and assessed its association with clinically relevant outcomes in relatively healthy, community‐dwelling individuals aged 70 and older.
Amanda J Rickard, Cammie Tran, Hans G Schneider, Flavia M Cicuttini, Anita E Wluka, Ego Seeman, Johannes T Neumann, Md Nazmul Karim, Zhen Zhou, Sultana Monira Hussain, David P Q Clark, Daniel Clayton‐Chubb, Andrew M Tonkin, Lawrence J Beilin, Robyn L Woods, John J McNeil   +15 more
wiley   +1 more source

Delayed Repolarization Caused by hERG Block With Different Drug Modalities Can Be Detected in Stem Cell-Derived Cardiomyocytes: Incubation Time Matters. [PDF]

Clin Transl Sci
Qu Y, Guo W, Wu B, Cui J, Gao B, Nichols JV, Vargas HM.   +6 more
europepmc   +1 more source

Chronic Opioids in Gout: A Matched Cohort Study from the Veteran's Health Administration

Arthritis Care &Research, Accepted Article.
Objective Though used frequently to treat flare, risk of chronic opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed chronic opioids over time.
Lindsay N. Helget, Bryant R. England, Punyasha Roul, Harlan Sayles, Tuhina Neogi, James R. O'Dell, Joshua F. Baker, Ted R. Mikuls   +7 more
wiley   +1 more source

No Evidence of QTc Interval Prolongation With Baxdrostat Treatment: Concentration-QTc Modeling Assessment. [PDF]

Pharmacol Res Perspect
Sunnåker M, Källgren C, Parkinson J, Dota C, Gottfridsson C, Janzén D, Andersson A, Carlson G.   +7 more
europepmc   +1 more source

PROLONGATION OF KIDNEY SURVIVAL DURING AND AFTER CYGLOSPORIN A THERAPY

, 1979
D C Dunn, David J. White, B. M. Herbertson, Judith A. Wade   +3 more
openalex   +1 more source

Cost‐effectiveness of low dose colchicine prophylaxis when starting allopurinol using the “start‐low go‐slow” approach for gout: evidence from a non‐inferiority randomised double‐blind placebo‐controlled trial.

Arthritis Care &Research, Accepted Article.
Objective The aim of this study was to investigate the cost‐effectiveness of low‐dose colchicine prophylaxis for preventing gout flares when starting allopurinol using the “start‐low go‐slow” approach. Methods Participants with gout, fulfilling the American College of Rheumatology recommendations for starting urate‐lowering therapy and with serum urate
Yana Pryymachenko, Ross Wilson, Nicola Dalbeth, J. Haxby Abbott, Lisa Stamp   +4 more
wiley   +1 more source

Decoding Silent Signals: A Systematic Review of ECG and the Quest for an Early Diagnosis of Cirrhotic Cardiomyopathy. [PDF]

Cureus
Neelakantan Ramaswamy S, Harikrishnan S, Bhatt N, Agarwal Y, Chand S, Bendagiri Matam M, Mohammed L.   +6 more
europepmc   +1 more source